Agios Pharmaceuticals, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2026

Published: 2026-04-29 08:51:55 ET AGIO

Published on 04/29/2026 at 08:51 am EDT

Agios Pharmaceuticals, Inc. reported earnings results for the first quarter ended March 31, 2026. For the first quarter, the company reported revenue was USD 20.75 million compared to USD 8.73 million a year ago. Net loss was USD 99.11 million compared to USD 89.29 million a year ago.

Basic loss per share from continuing operations was USD 1.69 compared to USD 1.55 a year ago. Diluted loss per share from continuing operations was USD 1.69 compared to USD 1.55 a year ago.